Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Akari Therapeutics
(NASDAQ:AKTX)
Intraday
$1.13
-0.06
[-5.04%]
After-Hours
$1.13
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.13
-0.06
[-5.04%]
At close: Apr 17
$1.13
0
[0.00%]
After Hours: 8:26AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Akari Therapeutics Stock (NASDAQ:AKTX)
Akari Therapeutics Stock (NASDAQ: AKTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 15, 2024
Akari Therapeutics To Present PAS-Nomacopan Pre-Clinical Electroretinography Data At ARVO 2024
Benzinga Newsdesk
-
Apr 15, 2024, 8:07AM
Monday, April 01, 2024
Akari Therapeutics shares are trading lower. The company reported FY23 financial results.
Benzinga Newsdesk
-
Apr 1, 2024, 1:49PM
Akari Therapeutics' Cash Of Approximately $3.8M As of December 31, 2023. In March 2024, It Raised Approximately $2M Via Private Placement And Is Planning To Secure Additional Capital In Q2 Of 2024
Benzinga Newsdesk
-
Apr 1, 2024, 6:35AM
Akari Therapeutics FY2023 EPS $0.00, Same YoY
Benzinga Newsdesk
-
Apr 1, 2024, 6:34AM
Tuesday, March 05, 2024
Akari Therapeutics And Peak Bio Announce Merger Of Equals; Exchange Is Expected To Result In Implied Equity Ownership In The Combined Company Of Approximately 50% For Akari Shareholders And Approximately 50% For Peak Stockholders
Benzinga Newsdesk
-
Mar 5, 2024, 8:03AM
Tuesday, January 02, 2024
Akari Therapeutics Closes Private Placement With Existing Investors For Gross Proceeds Of ~$2M
Benzinga Newsdesk
-
Jan 2, 2024, 8:01AM
Thursday, November 16, 2023
Akari Therapeutics Presents Poster On Progress In Pre-Clinical Development Of Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy At The 4th Annual Dry AMD Therapeutic Development Conference
Benzinga Newsdesk
-
Nov 16, 2023, 8:18AM
Monday, November 06, 2023
Akari Therapeutics To Present A Poster On Pre-Clinical Development Of Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy At The 4th Annual Dry AMD Therapeutic Development Conference
Benzinga Newsdesk
-
Nov 6, 2023, 8:49AM
Monday, October 30, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Oct 30, 2023, 5:31PM
Friday, October 13, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Oct 13, 2023, 9:06AM
Friday, September 29, 2023
Akari Therapeutics H1 2023 Net Loss Of $2.99M Versus $10.8M A Year Ago, Cash Balance Of Approximately $7.2M Sufficient To Fund Operations Into Q1 Of 2024
Benzinga Newsdesk
-
Sep 29, 2023, 8:04AM
Thursday, September 21, 2023
Akari Therapeutics Announces Existing Investors Support The Company Through A $2M Private Placement Financing, Company Also Receives $2.5M U.K. R&D Tax Credit
Benzinga Newsdesk
-
Sep 21, 2023, 8:22AM
Tuesday, September 05, 2023
Akari Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
Happy Mohamed
-
Sep 5, 2023, 8:19AM
Friday, August 18, 2023
Akari Therapeutics Announces Establishment Of Boston US Headquarters Office To Support Expanding Operations And Start Of Registrational Phase 3 Clinical Trials
Benzinga Newsdesk
-
Aug 18, 2023, 8:02AM
Thursday, August 17, 2023
Akari Therapeutics shares are trading lower after the company recently announced a ratio change of its American Depository Shares from 1-representing-100 to 1-representing-2000.
Benzinga Newsdesk
-
Aug 17, 2023, 3:02PM
Why NICE Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Aug 17, 2023, 12:26PM
Akari Therapeutics Plc American Depositary Shares Halted On Circuit Breaker To The Downside, Stock Now Down -15%
Happy Mohamed
-
Aug 17, 2023, 10:25AM
Akari Therapeutics Plc American Depositary Shares Resume Trade
Happy Mohamed
-
Aug 17, 2023, 10:23AM
Akari Therapeutics Plc American Depositary Shares Halted On Circuit Breaker To The Upside, Stock Now Down -9.16%
Happy Mohamed
-
Aug 17, 2023, 10:14AM
Tuesday, August 15, 2023
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Aug 15, 2023, 2:01PM
Akari Therapeutics shares are trading lower after the company announced a ratio change of its American Depository Shares from 1-representing-100 to 1-representing-2000.
Benzinga Newsdesk
-
Aug 15, 2023, 12:43PM
Akari Therapeutics, Plc Announces ADS Ratio Change From 1-Representing-100 To 1-Representing-2000; Ratio Change Is Expected To Be Effective On August 17, 2023
Happy Mohamed
-
Aug 15, 2023, 8:07AM
Monday, July 31, 2023
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Jul 31, 2023, 8:31AM
Thursday, July 27, 2023
Akari Therapeutics Granted Nomacopan Orphan Drug Designation From The European Commission For Treatment In Hematopoietic Stem Cell Transplantation
Happy Mohamed
-
Jul 27, 2023, 8:07AM
Tuesday, July 25, 2023
Akari Therapeutics Has Been Granted EU Orphan Designation Of Nomacopan For Treatment In Hematopoietic Stem Cell Transplantation
Happy Mohamed
-
Jul 25, 2023, 1:25PM
Thursday, July 13, 2023
Akari Therapeutics Provides Updates On Development Of Nomacopan In Pediatric And Adult HSCT-TMA
Happy Mohamed
-
Jul 13, 2023, 8:04AM
Tuesday, July 11, 2023
Akari Therapeutics Has Selected The Version Of Long-Acting PAS-Nomacopan That It Plans To Advance Into Clinical Trials; It Remains On Track For An IND Submission In 1H Of 2024 And The Start Of Clinical Trials In 2H Of 2024
Benzinga Newsdesk
-
Jul 11, 2023, 8:05AM
Thursday, July 06, 2023
Akari Therapeutics Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Nomacopan for Treatment in Hematopoietic Stem Cell Transplantation
Benzinga Newsdesk
-
Jul 6, 2023, 8:03AM
Friday, June 02, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jun 2, 2023, 9:07AM
Tuesday, May 16, 2023
Aspira Women's Health Names Torsten Hombeck As Chief Financial Officer Replacing Interim CFO Marlene McLennan, Effective June 15, 2023
Happy Mohamed
-
May 16, 2023, 4:17PM
Tuesday, April 25, 2023
Akari Therapeutics Granted 180-Day Extension By Nasdaq To Meet Minimum Bid Price Requirement
Michael Horton
-
Apr 25, 2023, 4:37PM
Friday, April 14, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Apr 14, 2023, 9:06AM
Wednesday, April 12, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Apr 12, 2023, 9:06AM
Friday, March 31, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Mar 31, 2023, 11:46AM
Thursday, March 30, 2023
Akari Therapeutics, Plc Announces $4M Registered Direct Offering
Bill Haddad
-
Mar 30, 2023, 9:10AM
Wednesday, March 29, 2023
Poland And U.K. Regulatory Authorities URPL And MHRA Approve Use Of New, Higher-Yielding Manufacturing Process For Nomacopan In Pivotal Clinical Study
Happy Mohamed
-
Mar 29, 2023, 8:28AM
Tuesday, March 28, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Mar 28, 2023, 1:43PM
Tuesday, March 14, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Mar 14, 2023, 1:24PM
Monday, March 13, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Mar 13, 2023, 5:32PM
Monday, March 06, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Mar 6, 2023, 4:31PM
Friday, March 03, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 3, 2023, 8:06AM
Tuesday, February 21, 2023
Akari Therapeutics Announces Presentation Of A Case Study From Phase 3 Part A Clinical Trial Of Nomacopan In Pediatric HSCT-TMA As A Late-Breaker At The Transplantation & Cellular Therapy Tandem Meetings
Happy Mohamed
-
Feb 21, 2023, 8:14AM
Monday, February 20, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Feb 20, 2023, 12:31PM
Wednesday, February 15, 2023
Akari Therapeutics Announced Updates On Progress In The Pre-clinical Development Program For Long-Acting PAS-Nomacopan As A Potential Treatment For Geographic Atrophy Secondary To Dry Age-related Macular Degeneration
Benzinga Newsdesk
-
Feb 15, 2023, 8:22AM
Monday, February 13, 2023
Akari Therapeutics Announces Acceleration Of The Phase 3 Clinical Trial Of Nomacopan For Treatment Of Pediatric HSCT-TMA Into Pivotal Part B And Addition Of A New Pipeline Program Developing Nomacopan For HSCT-TMA In Adults
Happy Mohamed
-
Feb 13, 2023, 8:12AM
Tuesday, January 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Jan 3, 2023, 12:54PM
Wednesday, December 21, 2022
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Dec 21, 2022, 1:51PM
Monday, December 05, 2022
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
Benzinga Insights
-
Dec 5, 2022, 10:01AM
HC Wainwright & Co. Initiates Coverage On Akari Therapeutics with Buy Rating, Announces Price Target of $1.5
Benzinga Newsdesk
-
Dec 5, 2022, 6:10AM
Tuesday, November 29, 2022
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Nov 29, 2022, 12:31PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch